Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), applauds the state of Utah which ...

Eli Lilly will partner with Nimbus Therapeutics to develop an oral treatment for obesity and other metabolic diseases, through a multi-year research collaboration and exclusive worldwide license ...

Incyte will partner with Genesis Therapeutics to research, discover, and develop small molecule treatments through a collaboration that could generate at least up to $620 million for Genesis, an ...

Building on their existing collaboration, the companies have signed a new agreement to focus on lead optimization of drug candidates identified by Variational AI’s Enki™ generative AI platform and ...

Scientists from UB and the Department of Energy’s Lawrence Berkeley National Laboratory have discovered “berkelocene,” the first organometallic molecule to be characterized containing the heavy ...

Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has emerged from scratch as a shining star, forged through a decade of relentless effort — growing from weakness to strength — ...

A research team from the University of Basel, Switzerland, has developed a new molecule modeled on plant photosynthesis: under the influence of light, it stores two positive and two negative charges ...

Conceptual illustration of the advancement of AI, showing humanity creating general AI, which in turn creates super AI. General AI, also known as strong AI, refers to AI that is designed to perform ...